BPA Sticks to Markets+ Leaning Despite Study Showing EDAM Benefits
E3 Analysis Provides ‘More Context and Nuance’ for Final Market Decision, Agency Says
E3's supplemental study on day-ahead market participation for BPA includes net-benefit estimates for the agency in multiple market footprints over three time frames. | E3
Nov 1, 2024
|
New findings from a much-anticipated study have “not shifted” BPA's staff recommendation that the agency choose SPP’s Markets+ over CAISO’s — despite results showing greater economic benefits from EDAM.
